vidarabine has been researched along with Glioma in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Achyut, BR; Allan, PW; Behbahani, T; Ealick, SE; Gilbert-Ross, M; Hong, J; Joshi, D; Parker, WB; Rab, R; Sorscher, EJ; Waud, WR | 1 |
Coen, DM; Malick, A; Markert, JM; Martuza, RL; Ruffner, KL | 1 |
Hayashi, M; Ishii, H; Ishii, Y; Kawano, H; Nakatsugawa, S; Satoh, K | 1 |
3 other study(ies) available for vidarabine and Glioma
Article | Year |
---|---|
The use of Trichomonas vaginalis purine nucleoside phosphorylase to activate fludarabine in the treatment of solid tumors.
Topics: Animals; Cell Line, Tumor; Escherichia coli; Genetic Therapy; Genetic Vectors; Glioma; Humans; Lentivirus; Mice; Mice, Nude; Purine-Nucleoside Phosphorylase; Squamous Cell Carcinoma of Head and Neck; Trichomonas vaginalis; Vidarabine | 2020 |
Experimental therapy of human glioma by means of a genetically engineered virus mutant.
Topics: Animals; Antiviral Agents; Brain Neoplasms; Cells, Cultured; Dose-Response Relationship, Drug; Foscarnet; Glioma; Mice; Mice, Nude; Mutagenesis; Phosphonoacetic Acid; Simplexvirus; Thymidine Kinase; Vidarabine; Viral Vaccines | 1991 |
[A trial of ACNU and radiation therapy with sensitizing agents for malignant gliomas].
Topics: Acyclovir; Adolescent; Adult; Aged; Brain Neoplasms; Bromodeoxyuridine; Combined Modality Therapy; Evaluation Studies as Topic; Female; Glioma; Humans; Male; Middle Aged; Nimustine; Radiation Injuries; Radiation-Sensitizing Agents; Radiotherapy Dosage; Remission Induction; Vidarabine | 1989 |